Orally Disintegrating Selegiline Allows Parkinson's Disease Patients to Lower Dopamine Agonist Dose
This is a discussion on Orally Disintegrating Selegiline Allows Parkinson's Disease Patients to Lower Dopamine Agonist Dose within the Other Clinical Pharmacy News forum, part of the Industry News and Updates category; Orally Disintegrating Selegiline Allows Parkinson's Disease Patients to Lower Dopamine Agonist Dose More......
|
|||||||
| Register | Help | Members List | Mark Forums Read |
06-30-2008, 03:01 PM
|
|||
|
|||
Orally Disintegrating Selegiline Allows Parkinson's Disease Patients to Lower Dopamine Agonist Dose
Orally Disintegrating Selegiline Allows Parkinson's Disease Patients to Lower Dopamine Agonist Dose
More... 
|
 |
«
Previous Thread
|
Next Thread
»
| Thread Tools | |
| Display Modes | |
Linear Mode
|
|
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| Eisai drug flunks Parkinson's trial | industry_news | Biotechnology News | 0 | 04-11-2008 03:39 PM |
| High-Dose Statin Therapy Useful for Patients With Heart and Kidney Disease Reuters Health Information, April 8, 2008 | industry_news | Other Clinical Pharmacy News | 0 | 04-08-2008 11:11 AM |
| Drug Shortage: Heparin sodium injection multidose and single dose vials, heparin flus | industry_news | FDA News | 0 | 03-04-2008 09:18 AM |
© 2008 DrugManagementForum™ powered by |
 |